AnnJMelvinMD

Pediatric Infectious Disease • Seattle, WA

Physician

Join to view full profile

Dr. Melvin is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Melvin's full profile

Already have an account?

Office
4800 Sand Point Way Ne
Seattle, WA 98105
Phone+1 206-987-2000

Education & Training

University of WashingtonFellowship, Pediatric Infectious Diseases, 1990 - 1993
University of California (San Francisco)Residency, Pediatrics, 1986 - 1987
Tulane University School of MedicineClass of 1986

Certifications & Licensure

WA State Medical License 1988 - 2026
LA State Medical License 1986 - 1987
American Board of Pediatrics Pediatric Infectious Diseases

Awards, Honors, & Recognition

Regional Top Doctor Castle Connolly, 2014

Clinical Trials

Anti-HIV Drug Regimens and Treatment-Switching Guidelines in HIV Infected Children Start of enrollment: 2002 Aug 01
Completed
Phase 2, Phase 3
A Comparison of Two Anti-HIV Drug Regimens for Youth Who Have Failed Prior Therapy
Completed
Phase 2
IMPAACT P1063: Safety and Effectiveness of Atorvastatin in HIV Infected Children and Adolescents With Hyperlipidemia Start of enrollment: 2009 Aug 01
Terminated
Phase 1, Phase 2
Safety, Tolerability, Drug Interactions, and Antiviral Activity of Rilpivirine in Antiretroviral-Naive HIV-Infected Children Less Than 12 Years of Age Start of enrollment: 2014 Sep 01
Withdrawn
Phase 1, Phase 2
Randomized Controlled Trial of Valganciclovir for Cytomegalovirus Infected Hearing Impaired Infants Start of enrollment: 2018 Aug 31
Active, not recruiting
Phase 2
Adolescent Master Protocol for Participants 18 Years of Age or Older - Lite Start of enrollment: 2017 Nov 01
Recruiting
Join now to see all

Publications & Presentations

PubMed

1 citations
Efficacy, Safety, and Tolerability of Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living With HIV: Results Throug...
Supattra Rungmaitree, Linda Aurpibul, Brookie M Best, Xiang Li, Meredith G Warshaw
Journal of the Pediatric Infectious Diseases Society. 2023-12-16
4 citations
A Cross-Sectional Survey of Pediatric Infectious Disease Physicians' Approach to Congenital Cytomegalovirus Infection.
Chieko Hoki, Michelle White, Megan H Pesch, Ann J Melvin, Albert H Park
International Journal of Neonatal Screening. 2023-03-24
1 citations
Pharmacokinetics, Tolerability, and Safety of Doravirine and Doravirine/Lamivudine/Tenofovir Disoproxil Fumarate Fixed-Dose Combination Tablets in Adolescents Living W...
Ann J Melvin, Ka Lai Yee, Kathryn P Gray, Mounika Yedla, Hong Wan
Journal of Acquired Immune Deficiency Syndromes. 2023-02-01

Grant Support

Pharmacokinetic &Safety Study Of Protease Inhibitor In Comb In HIV InfectedNational Center For Research Resources2007
Pactg(Pediatric AIDS Clinical Trial Group) 1058 : Pharmacokinetic StudiesNational Center For Research Resources2007
Pactg 1047: Study Of Quadrivalent Human Papillomavirus Virus LIKE Vaccine In HIVNational Center For Research Resources2007
Pharmacokinetic Amp;Safety Study Of Protease Inhibitor In Comb In HIV InfectedNational Center For Research Resources2006
Developmental Regulation Of Interferon GammaEunice Kennedy Shriver National Institute Of Child Health &Human Development1991–1992